TD Cowen reiterated a buy rating on Blue Owl Capital, while lowering its 12-month price target to $14 from $16, according to a report out Monday.
Source: US Top News and Analysis
News Aggregation on Steroids
TD Cowen reiterated a buy rating on Blue Owl Capital, while lowering its 12-month price target to $14 from $16, according to a report out Monday.
Source: US Top News and Analysis